← Back to news
Y

Yahoo Finance

Is AbbVie Inc. (ABBV) One of the Best Cancer Stocks to Invest In Now?

Y

Revolution Medicines, Inc. (RVMD) Net Loss Widens amid Progress on Clinical Trial Programs

Y

Arvinas, Inc. (ARVN) Makes Significant Progress on Oncology and Neurology Trials

Y

Guardant Health, Inc. (GH) Strengthens Health Technology Portfolio with MetaSight Diagnostics Acquisition

Y

Cogent Biosciences Inc. (COGT) Set for Bezuclastinib Launch, Awaiting FDA Approval

Y

Immunome, Inc. (IMNM) Sets Sights on $1B Opportunity amid Pipeline Development

Y

Syndax Pharmaceuticals Inc. (SNDX) on a Strong Footing amid Robust Demand for Key Flagship Drugs

Y

Schrödinger, Inc. (SDGR) Transition to Licensing Model Triggers Robust Revenue Growth

Y

Nuvation Bio Inc. (NUVB) Amends Protocol on Safusidenib Trials in Astrocytoma

Y

Summit Therapeutics Inc. (SMMT) Focused on Non-Small Cell Lung Cancer Trial of Ivonescimab

Y

Janux Therapeutics, Inc. (JANX) Commences Patient Dosing of JANX011 in Autoimmune Trial

Y

Analysts See $100 Oil on Strait of Hormuz Disruption

Y

EU can sharply cut local battery prices with Made in Europe plan, T&E report says

Y

BlackRock Ramps Up Risk in Its Target-Date Funds

Y

Dozens of Issuers Win Dual Share Class Approval. Rolling Them Out Won’t Be as Easy

Y

Wedbush Expands IVES Franchise With New Autocallable ETF

Y

Trump’s Retirement Savings Plan Offers Potential Bonanza for Firms Like Fidelity

Y

OpenAI Wins Pentagon Work as Altman Tries to Square Circular Deals after Raising $110B

Y

POWER DIGEST [March 2026]

Y

Engine Power Plants Surge as Data Centers Drive Unprecedented Demand

Y

Dow Jones Futures Fall, Oil Prices Jump Amid U.S.-Iran Attacks

Y

Oil Prices Soar Amid Escalating Middle East Conflict

Y

Oil climbs in early trading, diesel rising more than crude

Y

Risk-off assets surge as markets react to conflict in Iran

Y

AI disruption looms over markets with US jobs data on tap

Y

How China’s Rare Earth Ban Backfired into a U.S. Tech Breakthrough

Y

US stocks erase sharp losses, while oil prices leap on worries about Iran war

Y

International ETFs Lead as February Flows Top $190B

Y

China’s Oil Buying Spree May Be Running Out of Steam

Y